HomeHLUN-A • CPH
add
H Lundbeck A/S Class A
Previous close
kr 33.40
Day range
kr 33.45 - kr 34.40
Year range
kr 23.30 - kr 39.90
Market cap
39.26B DKK
Avg Volume
85.75K
P/E ratio
-
Dividend yield
-
Primary exchange
CPH
Market news
Financials
Income Statement
Revenue
Net income
| (DKK) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 6.09B | 9.96% |
Operating expense | 4.36B | 12.55% |
Net income | -27.00M | -104.58% |
Net profit margin | -0.44 | -104.13% |
Earnings per share | 0.94 | -30.88% |
EBITDA | 956.00M | -2.65% |
Effective tax rate | 107.50% | — |
Balance Sheet
Total assets
Total liabilities
| (DKK) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.43B | -26.39% |
Total assets | 52.05B | -9.72% |
Total liabilities | 27.15B | -16.84% |
Total equity | 24.90B | — |
Shares outstanding | 991.23M | — |
Price to book | 1.33 | — |
Return on assets | 2.33% | — |
Return on capital | 3.31% | — |
Cash Flow
Net change in cash
| (DKK) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -27.00M | -104.58% |
Cash from operations | 921.00M | 179.81% |
Cash from investing | -202.00M | 98.65% |
Cash from financing | -765.00M | -106.15% |
Net change in cash | -46.00M | 98.74% |
Free cash flow | 944.38M | -46.59% |
About
H. Lundbeck A/S, commonly referred to as Lundbeck, is a Danish international pharmaceutical company engaged in the research, development, manufacturing, marketing and sale of pharmaceuticals across the world. The company’s products are targeted at brain diseases, including depression, schizophrenia, Alzheimer's disease, Parkinson's disease and migraine. Wikipedia
Founded
Aug 14, 1915
Website
Employees
5,039
